NICE is gearing up to allow Alimera Sciences’ implant Iluvien to be used on the NHS as an option to …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

